VBI Vaccines to Present at the 2015 BIO International Convention
June 09, 2015 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., June 9, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") announced that it will be presenting at the 2015 BIO International Convention on Wednesday, June 17th at 11:30 AM...
VBI Vaccines Presents Data at the World Vaccine Congress Asia That Supports the Potential Use of Its eVLP Platform in the Development of a Novel Hepatitis C Vaccine Candidate
June 03, 2015 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., June 3, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") delivered a presentation, Enveloped Virus-Like Particles: Third-generation VLPs for the Development of a Broadly...
VBI Vaccines to Discuss the Manufacture of Enveloped Virus-Like Particles at the Modern Vaccines Adjuvants & Delivery Systems Conference
May 15, 2015 08:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., May 15, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") will deliver a presentation, Optimization of the Process for Making Clinical Supplies of an Enveloped Virus-like...
VBI Vaccines Announces New Data Supporting the Manufacture of Its Prophylactic CMV Vaccine Candidate
April 09, 2015 08:30 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., April 9, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") provided an update on the progress of its cytomegalovirus ("CMV") vaccine development program yesterday at the...
VBI Vaccines Announces Research Collaboration With Sanofi Pasteur to Enhance Vaccine Stability
April 06, 2015 16:30 ET
|
VBI Vaccines, Inc.
Sanofi Pasteur has chosen VBI's LPV™ technology to develop a more stable formulation of a key Sanofi Pasteur vaccine candidate.
The collaboration will leverage VBI's LPV™...
VBI Vaccines Partners with the Utah CMV Council to Raise CMV Awareness
February 12, 2015 14:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Feb. 12, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") is pleased to announce its sponsorship support of the Utah CMV Council and the End CMV Silence Gala, a fundraiser...
VBI Vaccines Partners with Le Classique to Raise CMV Awareness in Canada
January 08, 2015 13:00 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 8, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") is pleased to announce its sponsorship support of Le Classique, a 3-on-3 ball hockey tournament being held in...
VBI Vaccines to Present at the Noble Financial Capital Markets Equity Conference
January 06, 2015 16:30 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Jan. 6, 2015 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") will present at the Noble Financial Capital Markets Eleventh Annual Equity Conference on Tuesday, January 20th at...
VBI to Present at the LD Micro Conference
November 24, 2014 13:30 ET
|
VBI Vaccines, Inc.
Jeff Baxter, VBI's President and CEO, has been invited to speak at the LD Micro Conference in Los Angeles, CA on December 3rd, 2014.
CAMBRIDGE, Mass., Nov. 24, 2014 (GLOBE NEWSWIRE) -- VBI...
VBI Reports Third Quarter 2014 Financial Results and Provides Update on CMV Vaccine Development
November 14, 2014 16:05 ET
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Nov. 14, 2014 (GLOBE NEWSWIRE) -- VBI Vaccines (Nasdaq:VBIV) ("VBI") has filed operational and financial results for the three- and nine-month periods ended September 30th, 2014 on...